← Back to Search

Morning Bright Light Therapy for TBI

N/A

Recruiting

Led By Miranda M Lim, MD, PhD

Research Sponsored by Portland VA Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Must not have

History of macular degeneration

Decisionally impaired

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline; after 4 weeks of intervention; and 2 months after the end of intervention

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to determine the effect of morning bright light therapy on sleep quality in veterans with traumatic brain injury.

Who is the study for?

This trial is for Veterans who have experienced traumatic brain injury or stress disorders and are having trouble with their sleep. It's not suitable for those who don't speak English, have macular degeneration, decision-making impairments, bipolar disorder, or are already using light therapy.

What is being tested?

The study tests if Morning Bright Light Therapy (MBLT) can improve sleep quality in Veterans with traumatic brain injuries. Participants will use MBLT daily for 4 weeks and their sleep patterns will be monitored before, during, and three months after the therapy.

What are the potential side effects?

While the description doesn't specify side effects of MBLT, common ones may include eyestrain, headache or nausea. However, it's generally considered safe with minimal risks when used appropriately.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have a history of macular degeneration.

Select...

I am unable to make my own medical decisions.

Select...

I do not speak English.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline; after 4 weeks of intervention; and 2 months after the end of intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline; after 4 weeks of intervention; and 2 months after the end of intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline; after 4 weeks of intervention; and 2 months after the end of intervention for reporting.